Anne M. Vanlent's most recent trade in Trevi Therapeutics Inc was a trade of 45,000 Nonstatutory Stock Option (right to buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Trevi Therapeutics Inc | Anne M. Vanlent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 45,000 | 45,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Trevi Therapeutics Inc | Anne M. Vanlent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 30,000 | 30,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Trevi Therapeutics Inc | Anne M. Vanlent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 30,000 | 30,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Trevi Therapeutics Inc | Anne M. Vanlent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 20,000 | 20,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Trevi Therapeutics Inc | Anne M. Vanlent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 20,000 | 20,000 | - | - | Nonstatutory Stock Option (right to buy) |